Form 8-K - Current report:
SEC Accession No. 0001437749-24-027012
Filing Date
2024-08-15
Accepted
2024-08-15 16:06:58
Documents
16
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240815_8k.htm   iXBRL 8-K 33491
2 EXHIBIT 99.1 ex_715402.htm EX-99.1 122754
7 logosm.jpg GRAPHIC 10403
  Complete submission text file 0001437749-24-027012.txt   316528

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240812.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240812_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240812_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240812_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240815_8k_htm.xml XML 2820
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 241212443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)